The latest Ozempic and Mounjaro have helped the class of these medicines to grow faster
Serious side effects of weight loss peptides Serious side effects may also occur with GLP-1 medications, though they are rare and may include: Allergic reactions Inflammation of the pancreas (pancreatitis) Gallbladder problems Kidney problems Low blood sugar ( hypoglycemia ) in people with type 2 diabetes (especially when also using other medications that can lower blood sugar) Worsening of diabetic retinopathy (a condition that can cause blood vessel damage in the retina)in people with type 2 diabetes, particularly in those with pre-existing diabetic retinopathy Gastroparesis (severe slowing of stomach emptying) or, even more rarely, bowel obstruction GLP-1 medications contain a black box warning about the potential increased risk for certain thyroid tumors
Whilst there is no established contraindication to taking NAD+ supplements alongside GLP-1 therapies based on current evidence, the absence of safety data is not the same as confirmed safety
This is always a clinical decision, but some patterns have emerged in the way providers describe their prescribing preferences: Tirzepatide tends to be preferred for patients seeking maximum weight loss, patients with type 2 diabetes (where the dual mechanism helps glycemic control), and patients who have not responded adequately to semaglutide
In pathological conditions, the secretion pattern of PYY changes
That combination is why early retatrutide data looked almost implausibly good
